Filters
Serum gastrin levels enhance the noninvasive diagnosis of pernicious anaemia and lessen the need for endoscopy in B12-deficient patients with isolated anti-parietal cell antibodies (APCA), reports a study.
Treatment with daratumumab yields rapid and durable therapeutic effects and shows acceptable safety profile in adults with immune thrombocytopenia, according to a phase 2 trial.
Treatment with either dose of linaclotide (72 or 145 µg) showed improves bowel movement frequency and abdominal symptoms in adults with severe chronic idiopathic constipation (CIC), according to a post hoc pooled analysis of phase III studies presented at DDW 2026.
Individuals with low haemoglobin levels, especially those with elevated concentrations of Alzheimer’s disease (AD) biomarkers, are at greater risk of developing dementia, as suggested in new research.
Individuals with functional constipation (FC) may benefit from eating multicomponent and fruit-based foods, suggests a recent study.
Older adults have longer emergency department (ED) length of stay (LOS) and higher odds of admission than younger adults within the same triage category despite being assigned to higher acuity, reveals a Singapore study.
Both chest compression-only (CCO) cardiopulmonary resuscitation (CPR) and standard CPR produce comparable survival and neurological outcomes in adults with out-of-hospital cardiac arrest (OHCA), reports a study.
In treatment-seeking individuals with alcohol use disorder and obesity, semaglutide appears to help reduce alcohol consumption, as shown in a study.
The novel third-generation calcium channel modulator crisugabalin appears to be safe and efficacious in the treatment of central neuropathic pain, as shown in a phase 3 trial.
Coeliac disease does not appear to elevate the risk of cardiovascular events, reveals a study, adding that previous associations may have reflected residual confounding rather than a direct pathogenic link.
